Illumina, Inc. (ILMN) - Financial and Strategic SWOT Analysis Review

Date: April 19, 2017
Pages: 61
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: I8F10E02200EN
Leaflet:

Download PDF Leaflet

Illumina, Inc. (ILMN) - Financial and Strategic SWOT Analysis Review
Illumina, Inc. (ILMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Illumina, Inc. (Illumina) provides sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microarray kits and reagents; molecular biology reagents; and arrays and reagents. It offers human whole-genome sequencing; microarray services; and instrument services, training and consulting. Illumina caters its services to pharmaceutical companies, genomic research centers, academic institutions, biotechnology companies and clinical research organizations. The company's products are distributed to various countries through its distributors in Africa, Asia Pacific, Central America, Europe, the Middle East, North America, and South America. Illumina is headquartered in San Diego, California, the US.

Illumina, Inc. Key Recent Developments

Apr 20,2017: Personalis Orders Ten Illumina NovaSeq 6000 Systems for Immuno-Oncology Genomics and Large-Scale Whole Genome Sequencing
Apr 10,2017: CloudHealth Genomics Makes China's First Sequencing Data Available Using Illumina's NovaSeq 6000
Apr 03,2017: Illumina Advances the Use of Genomics in Precision Oncology, Donates Thousands of Somatic Interpretations to CIViC
Apr 03,2017: Novogene Adds 25 Illumina NovaSeq Sequencers
Mar 28,2017: Macrogen Leads Precision Medicine by Advancing the Realization of the '$100 Genome Age'

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Illumina, Inc. - Key Facts
Illumina, Inc. - Key Employees
Illumina, Inc. - Key Employee Biographies
Illumina, Inc. - Major Products and Services
Illumina, Inc. - Medical Equipment Pipeline Products Data
Illumina, Inc. Pipeline Products by Equipment Type
Illumina, Inc. Pipeline Products by Development Stage
Illumina, Inc. - History
Illumina, Inc. - Company Statement
Illumina, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Illumina, Inc. - Business Description
Illumina, Inc. - Corporate Strategy
Illumina, Inc. - SWOT Analysis
SWOT Analysis - Overview
Illumina, Inc. - Strengths
Illumina, Inc. - Weaknesses
Illumina, Inc. - Opportunities
Illumina, Inc. - Threats
Illumina, Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Illumina, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017
Illumina, Inc., Medical Equipment, Deals By Type, 2011 to YTD 2017
Illumina, Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 10, 2017: CloudHealth Genomics Makes China's First Sequencing Data Available Using Illumina's NovaSeq 6000
Apr 03, 2017: Illumina Advances the Use of Genomics in Precision Oncology, Donates Thousands of Somatic Interpretations to CIViC
Apr 03, 2017: Novogene Adds 25 Illumina NovaSeq Sequencers
Feb 20, 2017: Illumina Names John W. Thompson to Its Board of Directors, Bringing More Than 40 Years of Technology Leadership to Illumina
Jan 31, 2017: Illumina Reports Full Financial Results for Fourth Quarter and Fiscal Year 2016
Jan 27, 2017: Illumina Names Caroline Dorsa to Its Board of Directors, Adding Over 30 Years of Leadership Experience in the Healthcare, Telecommunications and Energy Industries
Jan 09, 2017: Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of Complex Diseases
Jan 09, 2017: Illumina Introduces the NovaSeq Series—a New Architecture Designed to Usher in the $100 Genome
Jan 03, 2017: Illumina Taps Garret Hampton, One of the World’s Leading Clinical Genomics Experts, to Head its Clinical Genomics Unit
Dec 20, 2016: Illumina Names Jonathan Seaton as Senior Vice President for Corporate & Business Development, Adding Further Clinical and Life Sciences Expertise to its Executive Team

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Illumina, Inc., Key Facts
Illumina, Inc., Key Employees
Illumina, Inc., Key Employee Biographies
Illumina, Inc., Major Products and Services
Illumina, Inc. Pipeline Products by Equipment Type
Illumina, Inc. Number of Pipeline Products by Development Stage
Illumina, Inc. Pipeline Products Summary by Development Stage
Illumina, Inc., History
Illumina, Inc., Other Locations
Illumina, Inc., Subsidiaries
Illumina, Inc., Joint Venture
Illumina, Inc., Key Competitors
Illumina, Inc., Ratios based on current share price
Illumina, Inc., Annual Ratios
Illumina, Inc., Annual Ratios (Cont.1)
Illumina, Inc., Annual Ratios (Cont.2)
Illumina, Inc., Interim Ratios
Illumina, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017
Illumina, Inc., Medical Equipment, Deals By Type, 2011 to YTD 2017
Illumina, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Illumina, Inc. Pipeline Products by Equipment Type
Illumina, Inc. Pipeline Products by Development Stage
Illumina, Inc., Performance Chart (2012 - 2016)
Illumina, Inc., Ratio Charts
Illumina, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017
Illumina, Inc., Medical Equipment, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Qiagen NV
Pacific Biosciences Inc
Luminex Corp
GenMark Diagnostics Inc
Agilent Technologies, Inc.
Affymetrix, Inc.
Skip to top


Ask Your Question

Illumina, Inc. (ILMN) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: